SHUR IQ • Response Brief
A transparent response to the American Heart Association’s pressure test — mapping every data source, distinguishing signal from inference, and charting the path forward.
Full data provenance for every finding in the SHUR IQ intelligence brief. Twelve sources, five knowledge graphs, zero black boxes.
| # | Source | Type | Date Range | Role in Analysis |
|---|---|---|---|---|
| 1 | Shawn Dennis Strategic Briefing | Primary interview | 2026-02-26 | Insider context, institutional knowledge, 30-year perspective |
| 2 | AHA 2030 Impact Goal Presidential Advisory | Policy document | 2024 | Strategic direction, stated goals, impact targets |
| 3 | AHA Strategic Policy Agenda 2024–2028 | Policy document | 2024 | Operational priorities, expansion areas |
| 4 | Go Red for Women Effectiveness Research | Peer-reviewed (PMC, TCTMD, AHA Journals) | 2004–2025 | Campaign performance trajectory, engagement data |
| 5 | AHA AI in Cardiovascular Care Guidance | AHA Circulation | 2024 | Technology positioning, AI strategy |
| 6 | Morning Consult Most Trusted Nonprofits | Survey data | 2022 | Trust benchmark (74.94 net trust score) |
| 7 | AHA 2024–25 Research Facts | AHA institutional report | 2024–25 | Investment figures ($6.1B+), research output |
| 8 | Jin et al., Circulation | Peer-reviewed | 2020 | Women in clinical trials (38%, 740 trials, 862,652 adults) |
| 9 | GAO-01-286R | Government audit | 2001 | Drug withdrawal gender risk data |
| 10 | Google SERP Landscape Analysis (5 queries) | InfraNodus network analysis | 2026-02-26 | Public discourse mapping, competitive positioning |
| 11 | InfraNodus Knowledge Graph (aha-business-intelligence) | Network graph theory | 2026-02-26 | Structural gap detection via betweenness centrality (95 nodes, 273 edges) |
| 12 | InfraNodus Brand Ontology Graph (aha-brand-score) | Network graph theory | 2026-02-27 | Brand dimension scoring (96 nodes, 192 edges) |
“Every number in our deliverable traces to a named source. Every structural finding traces to a measurable graph property. We distinguish between what the data shows and what it suggests.”SHUR IQ Methodology Standard
Morning Consult trust score: 74.94 (2022 survey data, 4,400+ respondents)
Research investment: $6.1B+ cumulative since 1949 (AHA Research Facts 2024–25)
Go Red revenue: $16M annual (AHA reported figures)
Aided brand recognition: ~85% among US adults (industry survey data)
Women in CV clinical trials: 38% (Jin et al., Circulation 2020 — 740 trials, 862,652 adults)
Drug withdrawal gender disparity: 8 of 10 drugs 1997–2000 (GAO-01-286R)
Knowledge graph structure: 95 nodes, 273 edges, 7 clusters, modularity 0.66 (computed, reproducible)
Inferred from structural disconnection between Trust cluster (48% betweenness) and Loyalty cluster in the brand ontology graph. The graph shows these clusters are not connected by any pathway, meaning trust is not flowing into engagement.
Inferred from: (a) 20-year campaign age, (b) stakeholder confirmation from Shawn Dennis, (c) graph isolation of the “Fundraising Impact” cluster from all other clusters. We note that engagement may be shifting rather than declining (addressed in Section 5).
Weighted rubric applied to mixed data. The 3.39/5.0 composite is a modeled output, not a survey result. Individual dimension scores blend observed data with structural analysis.
Observed that AHA has published AI guidance but has no consumer-facing product. The inference is that this creates competitive vulnerability. Whether this is strategic choice or gap depends on AHA’s internal roadmap.
Inferred from the pattern of sustained revenue ($16M) alongside reported engagement decline. Revenue is a lagging indicator; engagement is a leading indicator.
Ten identified gaps, each mapped to its specific evidence inputs. Every row traces a finding back to the data that produced it.
| Gap | Class | Primary Evidence | Graph Evidence | Observed or Inferred |
|---|---|---|---|---|
| 1. The Guru Gap | Structural | Shawn Dennis briefing: “they want to be a lifelong health partner” | Trust cluster (48% BC) disconnected from Loyalty cluster in brand graph | Inferred from structural disconnection |
| 2. Research-to-Impact Pipeline | Structural | $6.1B invested (AHA Facts) + declining community engagement (Shawn) | Research Funding cluster and Behavior Change cluster completely disconnected (modularity 0.66) | Observed ($6.1B) + Inferred (pipeline broken) |
| 3. Technology Platform Void | Structural | AHA Circulation 2024 AI guidance paper + no consumer product found in SERP | Tech Gap cluster (7% BC) — most isolated cluster in brand graph | Observed (no product) + Inferred (vulnerability) |
| 4. Behavior Change Science | Topical | BCTO and Health Belief Model absent from AHA public programs (SERP analysis) | Behavior Change cluster (5% influence) — lowest betweenness of any cluster | Observed (absence in public programs) |
| 5. Younger Women | Topical | Go Red effectiveness research showing lowest recognition in most vulnerable demographics | Maternal Health cluster disconnected from AI Medicine cluster | Observed (demographic data) + Inferred (gap worsening) |
| 6. Male Allies | Topical | Zero male-targeted content found in SERP analysis of AHA women’s health programs | No male engagement node exists in any graph cluster | Observed (complete absence) |
| 7. Health Equity Beyond Events | Depth | AHA Policy Agenda 2024–2028 references SDOH + no operational programs found | SDOH cluster referenced in policy but has zero connections to engagement clusters | Observed (policy exists) + Inferred (not operationalized) |
| 8. Self-Directed Prevention | Depth | Consumer wearables market analysis + AHA has no self-service tools | Technology gap confirmed by competitive SERP analysis | Observed (no tools) + Inferred (demand growing) |
| 9. Underresourced Communities | Audience | Gala model analysis: $16M from affluent donors + health equity mandate | Community Engagement cluster has no pathway to Fundraising Impact cluster | Observed (model structure) + Inferred (exclusionary) |
| 10. Clinicians as Advocates | Audience | AHA Guidelines shape practice but no clinician-to-patient advocacy content in SERP | Clinical authority cluster disconnected from community engagement | Inferred (pipeline absent) |
Our analysis was built entirely from public data, published research, and one strategic briefing. Here is exactly what internal AHA data would transform from inference to signal.
What it unlocks: Confirm whether engagement is truly declining or shifting to different channels. Currently inferred from campaign age and stakeholder testimony. Internal data would convert this to observed.
Timeframe needed: 2015–2026 annual
What it unlocks: Heart.org traffic trends, app download/usage data, email engagement rates. Would reveal whether traditional engagement decline is offset by digital growth.
Timeframe needed: 2020–2026 quarterly
What it unlocks: Replace our modeled Loyalty score (2.8/5.0) with actual retention rates and satisfaction data.
Timeframe needed: 2020–2026 annual
What it unlocks: Test the “health trust is local” hypothesis against actual chapter performance data. Currently structural inference.
Timeframe needed: Top 20 chapters, 2020–2026
What it unlocks: We now know AHA has a personalization initiative, preference center, and XM Cloud deployment. Access to this data would dramatically reshape our technology gap assessment — AHA may be further along than public-facing evidence suggests.
Timeframe needed: Current platform capabilities and engagement metrics
What it unlocks: Map our external findings against AHA’s own strategic priorities. Identify true gaps (where we see problems they haven’t identified) vs. known gaps (where they’re already working on solutions).
This was referenced by Shawn: “The library AHA wouldn’t share.”
AHA asked how it compares to key health competitors. We expanded our analysis beyond nonprofits to include the technology platforms that are actually capturing daily health relationships.
| Organization | Authority (Science) | Engagement (Daily) | Daily Relevance | AHA Advantage | AHA Vulnerability |
|---|---|---|---|---|---|
| Apple Health | Low (device maker, not researcher) | Very High (wrist-level, 24/7) | Very High (Watch + iPhone) | $6.1B research, clinical guidelines, scientific credibility | No consumer product; Apple building the daily relationship AHA wants |
| Google Health | Medium (DeepMind research) | High (Search + Fitbit + Android) | Very High (default health search) | Trusted nonprofit vs. ad-funded tech; AHA Guidelines outrank Google AI | Google owns the information layer; AHA is a source, not the destination |
| Whoop | Low (no research base) | Very High (continuous biometrics) | High (subscription model, daily scores) | Scientific credibility, clinical validation | Whoop creates behavioral loyalty through daily data that AHA cannot replicate without a platform |
| Mayo Clinic | Very High (peer institution) | Medium (destination, not daily) | Low (visit-based) | National reach, volunteer/fundraising base | Mayo building consumer digital tools (Mayo Clinic Platform) faster than AHA |
| Cleveland Clinic | Very High (peer institution) | Medium (destination, not daily) | Medium (Health Essentials content) | Broader mission scope, fundraising infrastructure | Cleveland Clinic’s content strategy is more consumer-friendly |
| CDC | Very High (government authority) | Low (guideline issuer) | Low (crisis-only salience) | AHA perceived as warmer, more actionable | CDC has policy enforcement power AHA lacks |
| St. Jude | Medium (disease-specific) | Very High (emotional engagement) | Medium (donation model) | Broader health scope | St. Jude’s emotional narrative converts trust to loyalty far more effectively (est. BPS ~4.3 vs AHA 3.39) |
| American Cancer Society | High (peer nonprofit) | Medium | Low (similar model to AHA) | Heart disease kills more Americans | ACS facing same challenges; neither has solved the engagement problem |
“The competitive threat to AHA is not another nonprofit. It’s the technology platform that becomes the default daily health relationship — and right now, that’s Apple, Google, and Whoop.”SHUR IQ Competitive Analysis — April 2026
AHA’s AI expert asked a critical question: Is engagement actually declining, or is it shifting across channels and formats? This is the right question, and the honest answer is: we don’t have enough data to say definitively. Here’s what we know and what we don’t.
Internal digital analytics from AHA would convert this from inference to signal. If heart.org traffic is growing, app engagement is rising, and the preference center is capturing first-party data, then engagement is shifting, not declining. If those metrics are also flat or declining, then the decline thesis is confirmed.
This is the single most important data gap in our analysis. Whether engagement is declining or shifting determines whether AHA needs a rescue strategy or an acceleration strategy. We recommend AHA share digital engagement metrics to resolve this before any strategic decisions are made based on our findings.
Why this is #1: Every signal in our analysis — the Guru Gap, the technology platform void, the competitive landscape — points to the same conclusion. AHA’s scientific authority is its greatest asset, but it has no mechanism to deliver that authority into someone’s daily life. Apple Health, Google, and Whoop are filling this space by default.
What to do: Within 12 months, establish a technology partnership that puts AHA-validated health insights into a consumer’s daily routine. This could be an AHA-branded layer on Apple Watch (AHA just voted an Apple Health doctor onto its board), an AHA health score powered by wearable data, or an API that feeds AHA guidelines into existing health platforms.
Why now: The XM Cloud and preference center infrastructure AHA is building creates the data backbone. A technology partnership would connect that backbone to a consumer touchpoint. Without the consumer layer, AHA will remain the world’s most trusted health organization that nobody interacts with daily.
Evidence base: Technology Platform Void (Gap 3), Competitive Landscape analysis (Section IV), Shawn Dennis insider confirmation (“they stay away from choosing a technology... they’re losing the branding”)
Why this is #2: Go Red has 22 years of brand equity and $16M in annual revenue. But revenue is a lagging indicator of engagement, and the campaign was designed for a pre-digital era. Rather than retire Go Red, evolve it into a year-round digital prevention platform.
What to do: Transform Go Red from an annual awareness event to a continuous engagement platform. Use behavior change science (BCTO, Health Belief Model) — which AHA’s own research supports but its programs don’t use — to design digital interventions. Deploy through the preference center and personalization initiative already underway.
Why now: AHA has the ingredients — the personalization initiative, the preference center, XM Cloud, the scientific authority. What’s missing is a consumer-facing product that uses those ingredients. Go Red’s existing brand recognition (among 45+ demographics) provides a launch platform.
Evidence base: Campaign fatigue data (Gap 1), Behavior Change Science absence (Gap 4), Shawn Dennis: “They haven’t figured it out... you raise a billion dollars a year”
Why this is #3: Six in ten women will have heart disease by 2050 (AHA Circulation, Feb 2026). AHA’s policy agenda references maternal health. But there is no connection between AHA’s AI vision and its women’s health mandate — this bridge doesn’t exist. Wearable-powered maternal cardiovascular monitoring could be AHA’s signature innovation and a genuine life-saving capability.
What to do: Launch an AHA Maternal Heart Health Initiative that combines wearable monitoring, AI-powered risk detection, and community support. Partner with a wearable manufacturer for a clinical validation study. Use the results to publish AHA-backed maternal health monitoring guidelines — extending AHA’s scientific moat into a new domain.
Why now: The maternal health crisis is accelerating. Shawn’s colleague lost a sister in childbirth from an undetected heart condition. The emotional and clinical urgency is undeniable. AHA’s scientific authority gives it unique credibility to lead here. No technology company can publish clinical guidelines.
Evidence base: Maternal Intelligence Gap (Gap 5), AHA Circulation Feb 2026 data, post-call emotional validation, AI/Wearable SERP analysis, Shawn Dennis colleague personal story
AHA’s team posed six internal strategic questions. We can offer directional perspective on each, while acknowledging that only AHA has the internal data to fully answer them.
The health score on someone’s wrist. The risk alert on their phone. The nutrition guidance in their grocery app. The daily wellness check-in tied to their wearable data. Right now, Apple and Google own these touchpoints. AHA’s scientific authority could power the intelligence layer behind any of these — but only through partnership or platform development. The preference center and personalization work already underway is the foundation.
Based on the feedback, more places than our original analysis captured. The personalization initiative addresses the Guru Gap at a technology level. The preference center addresses the data infrastructure gap. XM Cloud addresses the platform gap. Our original analysis was built from public data — these internal initiatives were invisible to us. We’d welcome the chance to re-score with this information included.
Scientific authority (Awareness 4.0, Trust 3.7 in our scoring) is genuinely world-class. AHA Guidelines are the gold standard in cardiovascular medicine. The research investment ($6.1B+) is an unreplicable moat. We captured these strengths — they’re the highest-scoring dimensions. What we may be missing: internal digital engagement growth, chapter-level innovation, and the technology initiatives now revealed.
Three things no competitor can match: (1) $6.1B in cumulative cardiovascular research and the clinical guidelines that result from it — no tech company can publish AHA-quality guidelines; (2) the trust score (74.94, Morning Consult) built over 100 years; (3) the volunteer network and chapter system that reaches communities at local level. These are 100-year moats. The risk is that these moats are defensive (preventing erosion) rather than offensive (driving growth).
Based on our analysis: (1) Consumer digital product development capability — AHA publishes research and guidelines but doesn’t build consumer-facing products; (2) Behavior change design capability — the science exists (BCTO, Health Belief Model) but isn’t operationalized in programs; (3) Real-time data integration — connecting wearable data to AHA guidance requires API infrastructure, health data compliance, and ML/AI capability.
Directly. The personalization initiative + preference center + XM Cloud form the data and delivery backbone. Our Gap 1 (Guru Gap) is essentially what these initiatives are designed to close. Our recommendation would be: use our competitive landscape analysis and gap classification to prioritize which personalization use cases to build first — starting with the daily health relationship (Action 1) and Go Red digital evolution (Action 2).
The questions AHA asked are themselves data. They reveal strategic context that strengthens the analysis.
The mention of personalization, preference center, and XM Cloud tells us AHA has significant technology infrastructure underway. This shifts our technology gap assessment: AHA may not have a platform absence — it may have a visibility gap. The infrastructure exists but isn’t consumer-facing yet.
AHA’s AI expert asking about signal vs. inference shows analytical sophistication. This is not a team that wants buzzwords — they want evidence trails. Future deliverables should include an explicit evidence classification for every finding.
“Determine which of these actually match what we want in the future” — this is procurement language. They’ve accepted the analysis as directionally valid. Now they’re evaluating which findings to act on. This is Phase 2 territory.
AHA asked “Where are we already strong that this analysis may be missing?” — this suggests they feel our report may underweight their strengths. The next version should explicitly map AHA strengths against each gap to show we recognize what’s working.